AbDiver - A tool to explore the natural antibody landscape to aid therapeutic design
Jakub Młokosiewicz, Piotr Deszyński, Wiktoria Wilman, Igor JaszczyszyniD, Rajkumar GanesaniD, Aleksandr KovaltsukiD, Jinwoo LeemiD, Jacob D. GalsoniD, Konrad KrawczykiD
Abstract
MotivationRational design of therapeutic antibodies can be improved by harnessing the natural sequence diversity of these molecules. Our understanding of the diversity of antibodies has recently been greatly facilitated through the deposition of hundreds of millions of human antibody sequences in next-generation sequencing (NGS) repositories. Contrasting a query therapeutic antibody sequence to naturally observed diversity in similar antibody sequences from NGS can provide a mutational road-map for antibody engineers designing biotherapeutics. Because of the sheer scale of the antibody NGS datasets, performing queries across them is computationally challenging. ResultsTo facilitate harnessing antibody NGS data, we developed AbDiver (http://naturalantibody.com/abdiver), a free portal allowing users to compare their query sequences to those observed in the natural repertoires. AbDiver offers three antibody-specific use-cases: 1) compare a query antibody to positional variability statistics precomputed from multiple independent studies 2) retrieve close full variable sequence matches to a query antibody and 3) retrieve CDR3 or clonotype matches to a query antibody. We applied our system to a set of 742 therapeutic antibodies, demonstrating that for each use-case our system can retrieve relevant results for most sequences. AbDiver facilitates the navigation of vast antibody mutation space for the purpose of rational therapeutic antibody design and engineering. AvailabilityAbDiver is freely accessible at http://naturalantibody.com/abdiver.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 19
- FWCI
- 2.42
- Field percentile
- top 11%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Konrad Krawczyk, Matthew I. J. Raybould, … Charlotte Mary Deane·mAbsPeer-reviewed·Jun 20, 2019
- Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Habib Bashour, Eva Smorodina, … Victor Greiff·Communications BiologyPeer-reviewed·Jul 31, 2024
- Computational design of structurally diverse antibody repertoires with drug-like properties
Ariel Tennenhouse, Rebecca E Wilen, … Sarel Jacob Fleishman·bioRxiv·Jul 13, 2026
- Data mining patented antibody sequences
Konrad Krawczyk, Andrew G. Buchanan, Paolo Marcatili·mAbsPeer-reviewed·Jan 1, 2021
- Assessment of Antibody Library Diversity through Next Generation Sequencing and Technical Error Compensation.
Marco Fantini, Luca Pandolfini, … Antonino Cattaneo·PLoS ONEPeer-reviewed·May 15, 2017
- Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations
Frédéric A. Dreyer, Constantin Schneider, … Charlotte Mary Deane·bioRxiv·Oct 3, 2024